Development of cholinergic inhibitory capacities in the hyperthyroid mouse.
The ontogeny of behavioral arousal and inhibition, as measured by spontaneous locomotor activity, was compared in four experiments for controls and mice injected with thyroxine as neonates. Mice treated with thyroxine at 1-3 days of age had higher activity levels at 10-15 days of age than controls, suggesting potentiation of arousal systems by the hormone treatment. Although thyroxine-accelerated development had no reliable effect upon the age at which peak activity occurred, scopolamine injections increased activity as early as 15 days of age in thyroxine-treated mice, whereas saline-treated or unhandled controls did not show a similar increase until 16-17 days of age. The findings were interpreted as indicating both a potentiation of arousal and a compensatory acceleration of cholinergic inhibitory capacities as a result of the neonatal hyperthyroidism. In addition, the importance of the behaviorally suppressive effects of a novel injection experience in the neonatal mouse was demonstrated.
D000375:Aging; D000818:Animals; D000831:Animals, Newborn; D003864:Depression, Chemical; D006980:Hyperthyroidism / Q000503:physiopathology*; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D010275:Parasympathetic Nervous System / Q000503:physiopathology*; D012601:Scopolamine / Q000494:pharmacology; D013974:Thyroxine / Q000494:pharmacology
D012601:Scopolamine; D013974:Thyroxine